Abstract: Medical containers are provided, wherein the containers may be used to transport medical devices. The medical container can include a front panel, a rear panel, and a lower panel cooperating to form a cavity. The lower panel may include an absorbent material. The medical container may also include one or more absorbent band members disposed around at least a portion of the circumference of the cavity. An insert portion including a front panel, a rear panel, and a lower panel may be coupled to or disposed within the medical container. The insert portion may be formed from an absorbent material. Methods of using the medical containers are also provided.

Abstract: A medical appliance or prosthesis may comprise one or more layers of rotational spun nanofibers, including rotational spun polymers. The rotational spun material may comprise layers including layers of polytetrafluoroethylene (PTFE). Rotational spun nanofiber mats of certain porosities may permit tissue ingrowth into or attachment to the prosthesis. Additionally, one or more cuffs may be configured to allow tissue ingrowth to anchor the prosthesis.

Abstract: A stent or other prosthesis may be formed by coating a single continuous wire scaffold with a polymer coating. The polymer coating may consist of layers of electrospun polytetrafluoroethylene (PTFE). Electrospun PTFE of certain porosities may permit endothelial cell growth within the prosthesis.

Abstract: A stent or other prosthesis may be formed by coating a single continuous wire scaffold with a polymer coating. The polymer coating may consist of layers of electrospun polytetrafluoroethylene (PTFE). Electrospun PTFE of certain porosities may permit endothelial cell growth within the prosthesis.

Abstract: A computer-implemented method including, transmitting a high-spectrum energy wave towards a subject from a first sensor and transmitting a low-spectrum energy wave towards the subject from a second sensor. In response, modulation with a carrier sequence code results in a modulated evoked biological signal. The carrier sequence code has an autocorrelation function. The method includes demodulating the modulated evoked biological signal by calculating a convolution of the modulated evoked biological signal with the carrier sequence code resulting in an evoked biological signal spectrum. The evoked biological signal spectrum has a peak to sideband ratio as a function of the carrier sequence code. The method includes calculating deviations between each element of the sampled evoked biological signal and the peak to sideband ratio and filtering noise artifacts from the sampled evoked biological signal based on the deviations.

Abstract: Medical containers are provided, wherein the containers may be used to transport medical devices. The medical container can include a front panel, a rear panel, and a lower panel cooperating to form a cavity. The lower panel may include an absorbent material. The medical container may also include one or more absorbent band members disposed around at least a portion of the circumference of the cavity. An insert portion including a front panel, a rear panel, and a lower panel may be coupled to or disposed within the medical container. The insert portion may be formed from an absorbent material. Methods of using the medical containers are also provided.

Abstract: A medical appliance or prosthesis may comprise one or more layers of electrospun nanofibers, including electrospun polymers. The electrospun material may comprise layers including layers of polytetrafluoroethylene (PTFE). Electrospun nanofiber mats of certain porosities may permit tissue ingrowth into or attachment to the prosthesis.

Abstract: A computer-implemented method for biological signal recording, including modulating a sampled evoked biological signal with a carrier sequence code resulting in a modulated evoked biological signal. The carrier sequence code has an autocorrelation function. The method includes demodulating the modulated evoked biological signal by calculating a convolution of the modulated evoked biological signal with the carrier sequence code resulting in an evoked biological signal spectrum. The evoked biological signal spectrum has a peak to sideband ratio as a function of the carrier sequence code. The method includes calculating deviations between each element of the sampled evoked biological signal and the peak to sideband ratio and filtering noise artifacts from the sampled evoked biological signal based on the deviations. Peak to sideband ratios may also be optimized by varying the sampling rate.

Abstract: An embolic filter balloon is disclosed. The embolic filter balloon may comprise an inflatable balloon portion. Further, the inflatable balloon portion may be coupled to a filter member. The embolic filter balloon may be disposed in a body lumen. In some embodiments, the embolic filter balloon may be configured such that when the inflatable balloon portion is at least partially inflated the filter member extends at least partially across the body lumen. Such a configuration may allow the embolic filter balloon, when deployed, to filter particles greater than a predetermined size from a fluid in the body lumen.

Abstract: A fluid measurement system includes a signal processor and a processing system. The signal processor is configured and adapted to produce a serial word that is indicative of a fluid characteristic that is configured to be communicated externally of the signal processor. The processing system is operatively connected to the signal processor to read the serial word and decode the serial word. A method for transmitting a fluid characteristic between a sensor system and a processing system includes producing a serial word that is indicative of a fluid characteristic value with a signal processor. The method includes transmitting the serial word externally of the signal processor. The method includes reading and decoding the serial word with a processing system to determine the fluid characteristic value.

Abstract: A vascular prosthesis deployment device and related methods are disclosed. In some embodiments the deployment device may provide audible, tactile, or visual feedback to a practitioner as to the degree of deployment of a prosthesis. The deployment device may also provide mechanical advantage when deploying a prosthesis. The deployment device may be configured to incrementally deploy a prosthesis.

Abstract: A method and a system for determining changes in a body state of an individual including receiving a signal from a monitoring system, where the signal indicates a measurement of cardiac activity of the individual over a period of time and determining at least one signal feature, where the signal feature is a reoccurring event of the signal over the period of time. The method also includes determining a first interval between two successive signal features and determining a second interval between two successive first intervals. A derivative is calculated based on the second interval. Changes in the body state are identified based on the derivative.

Abstract: An embolic filter balloon is disclosed. The embolic filter balloon may comprise an inflatable balloon portion. Further, the inflatable balloon portion may be coupled to a filter member. The embolic filter balloon may be disposed in a body lumen. In some embodiments, the embolic filter balloon may be configured such that when the inflatable balloon portion is at least partially inflated the filter member extends at least partially across the body lumen. Such a configuration may allow the embolic filter balloon, when deployed, to filter particles greater than a predetermined size from a fluid in the body lumen.

Abstract: Medical devices and related method for improving blood flow to regions of a patient are described herein. Some medical devices may include a first graft portion, a second graft portion, and a catheter portion disposed between the first graft portion and the second graft portion. The medical device may be implanted into a patient to establish a non-natural flow path.

Abstract: Medical devices and related method for improving blood flow to regions of a patient are described herein. Some medical devices may include a first graft portion, a second graft portion, and a catheter portion disposed between the first graft portion and the second graft portion. The medical device may be implanted into a patient to establish a non-natural flow path.

Abstract: A method and a system for determining an information transfer rate between a driver and a vehicle, including measuring driver information and measuring vehicle information. Further, calculating a forward information transfer rate from the driver to the vehicle using the driver information and the vehicle information over a period of time, and calculating a reverse information transfer rate from the vehicle to the driver using the driver information and the vehicle information over the period of time. Additionally the method includes, calculating a driver control state using the forward information transfer rate and the reverse information transfer rate.

Abstract: Methods of declotting vascular access technologies, such as vascular access assemblies that facilitate hemodialysis, are provided. The methods can include disposing a catheter within a patient to access a vascular access assembly within the heart of the patient. The catheter can be coupled to the vascular access assembly such that a clot can be evacuated from within the vascular access assembly via the catheter.

Abstract: Devices used to pressurize, depressurize, or otherwise displace fluid are disclosed. The devices may be configured to displace fluid in order to inflate or deflate a medical device, such as a balloon. The devices further include a crank member for providing a mechanical advantage when pressurizing or otherwise displacing fluid.